Vioxx Case Update
January 23rd, 2008Cuming, Gillespie & Raymaker continue to proceed with the Canadian National Class Action with respect to the Vioxx claims.
The Vioxx claims within the U.S. only have been resolved for the sum of $4,850,000.00 dollars pursuant to an agreement between Merck & Co. Inc and a six member negotiating committee on behalf of all U.S. Plaintiffs. The details of the U.S. settlement are available online at www.officialvioxxsettlement.com.
The claim has not resolved and will be proceeding to a certification hearing in 2008.